BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3573341)

  • 1. [Polycythemia vera associated with marked pancytopenia in transition from the polycythemic stage to leukemia--a case report].
    Kamei T; Iwasa S; Okuda K; Izeki T; Kanazawa S; Kondo H; Okuda K; Yonemitsu H
    Rinsho Ketsueki; 1987 Feb; 28(2):239-43. PubMed ID: 3573341
    [No Abstract]   [Full Text] [Related]  

  • 2. Mitobronitol: an alkylating agent that does not induce extra leukemia cases if applied as pulse therapy for polycythemia vera.
    Kelemen E; Tura S
    Ann N Y Acad Sci; 1985; 459():335. PubMed ID: 3938195
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of polycythemia vera with dibromomannitol (author's transl)].
    Yonemitsu H; Kanazawa S; Kondo H; Yamaguchi K; Okuda K; Shigeta H
    Rinsho Ketsueki; 1980 May; 21(5):587-91. PubMed ID: 6774132
    [No Abstract]   [Full Text] [Related]  

  • 4. [Acute leukemia and primary Vaquez' polycythemia. 20 cases].
    Bernard JF; Renoux M; Dhermy D; Schneider M; Chouraqui F; Amar M; Boivin P
    Sem Hop; 1978 Sep 18-25; 54(25-28):797-804. PubMed ID: 214857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute leukemia in polycythemia vera.
    Pedersen-Bjergaard J; Philip P
    N Engl J Med; 1981 Aug; 305(6):342-3. PubMed ID: 7242637
    [No Abstract]   [Full Text] [Related]  

  • 6. Tumor lysis syndrome induced by hydroxyurea therapy for leukemic transformation of polycythemia vera.
    Ellis AK; Lee DH
    Am J Hematol; 2002 Nov; 71(3):237-8. PubMed ID: 12410589
    [No Abstract]   [Full Text] [Related]  

  • 7. Course and transformation of polycythaemia vera in relation to therapy.
    Burger T; Schmelczer M; Molnár L; Pajor L; Koszorus S
    Acta Med Hung; 1988; 45(1):97-113. PubMed ID: 3412864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular and neoplastic risk in a large cohort of patients with polycythemia vera.
    Marchioli R; Finazzi G; Landolfi R; Kutti J; Gisslinger H; Patrono C; Marilus R; Villegas A; Tognoni G; Barbui T
    J Clin Oncol; 2005 Apr; 23(10):2224-32. PubMed ID: 15710945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Short-term massive myelobromol therapy in polycythemia vera: a 12-years' experience. Model for a clinical trial of cytostatic drugs].
    Kelemen E
    Orv Hetil; 1983 Jan; 124(1):3-13. PubMed ID: 6402751
    [No Abstract]   [Full Text] [Related]  

  • 10. [A clinical study of sixteen polycythemia vera cases--acute myeloblastic leukemia in patients with polycythemia vera].
    Takeyama H; Shimokawa T; Yamada H; Watanabe E
    Gan To Kagaku Ryoho; 1994 Dec; 21(16):2833-7. PubMed ID: 7993124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [30 cases of myeloid metaplasia and 5 cases of acute leukemia in a group of 200 cases of polycythemia vera].
    Nicoară S; Butoianu E; Ciocoiu A; Coliţă A; Grigoriu G; Vîlcu A; Ursea C; Dosius L; Niculescu R
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1983; 35(3):261-6. PubMed ID: 6140721
    [No Abstract]   [Full Text] [Related]  

  • 12. Resistance to therapy of acute leukemia developing in the course of polycythemia vera.
    Donovan PB; Landaw SA; Dresch C; Gartenhaus WS; Goldberg JD; Ellis JT; Loeb V; Perry MC; Petitt RM; Pisciotta AV; Silver RT; Spurr CL; Weinfeld A; Berk PD
    Nouv Rev Fr Hematol (1978); 1981; 23(4):187-92. PubMed ID: 7312612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute myeloid leukemia occurring in a patient with polycythemia vera in treatment with hydroxyurea.
    Cacciola E; Cacciola RR; Guglielmo P; Stagno F; Giustolisi R
    Haematologica; 1999 Aug; 84(8):755-6. PubMed ID: 10457418
    [No Abstract]   [Full Text] [Related]  

  • 14. [Current aspects of the treatment of polycythemia vera under polyclinical conditions].
    Osechenskaia GV; Krasiukova LI
    Probl Gematol Pereliv Krovi; 1978 Jan; 23(1):21-4. PubMed ID: 628661
    [No Abstract]   [Full Text] [Related]  

  • 15. Transformation of polycythemia vera to acute promyelocytic leukemia.
    Kajiguchi T; Simokawa T; Saito M; Takeyama H
    Int J Hematol; 2000 Dec; 72(4):520-1. PubMed ID: 11197225
    [No Abstract]   [Full Text] [Related]  

  • 16. [Leukemic transformation of polycythemia vera after treatment with hydroxyurea and chromosome 17 abnormalities].
    Tóthová E; Nebesnáková E; Kafková A; Stecová N; Fricová M
    Vnitr Lek; 1999 Aug; 45(8):487-9. PubMed ID: 11045151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypereosinophilic syndrome associated with polycythemia vera.
    Varon D; Wetzler M; Berrebi A
    Arch Intern Med; 1986 Jul; 146(7):1440-1. PubMed ID: 3718142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukemia-associated antigens in leukemic transformation of polycythemia vera.
    Pisciotta AV; Cronkite C; Hanson GA; Brodsky JB; Donovan PB; Wasserman LR
    J Lab Clin Med; 1983 Mar; 101(3):432-40. PubMed ID: 6827175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effectiveness of cytostatic therapy of polycythemia vera].
    Kovaleva LG; Kho PI
    Gematol Transfuziol; 1986 Jul; 31(7):42-6. PubMed ID: 3744014
    [No Abstract]   [Full Text] [Related]  

  • 20. Pyridoxin-responsive anaemia in a patient with a history of polycythaemia vera.
    Van Gameren II; Wijnja L; Louwes H; de Wolf JT
    J Intern Med; 1997 Jul; 242(1):79-81. PubMed ID: 9260571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.